| Methods |
Random allocation: Yes; Concealed allocation: No; Baseline comparability: No; Blind assessors: Yes; Blind subjects: Yes; Blind therapists: No; Adequate follow‐up: Yes; Intention‐to‐treat analysis: No; Between‐group comparisons: Yes; Point estimates & variability: Yes; Eligibility criteria: Yes |
| Participants |
20 participants (mean age 48) with supraspinatus and biceps tendonitis, full range of passive movement with pain on resisted abduction and pain on resisted elbow flexion and supination. |
| Interventions |
Group 1:Active infrared laser therapy at 904nm 3 times a week for 2 weeks.Group 2: Placebo laser therapy at same frequency.Group 3: Naproxen sodium 550mg 2 times a day for 2 weeks. |
| Outcomes |
Outcomes (0 and 2 weeks)1.Active range of shoulder flexion, abduction and extension 2.Subjective rating of benefit with respect to pain, stiffness and function as measured on a 10cm VAS |
| Notes |
Results presented as difference between medians. Refer additional table |
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Allocation concealment (selection bias) |
Unclear risk |
B ‐ Unclear |
